These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Halliday G; Robinson SR; Shepherd C; Kril J Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521 [TBL] [Abstract][Full Text] [Related]
23. Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology. Fonseca MI; McGuire SO; Counts SE; Tenner AJ J Neuroinflammation; 2013 Feb; 10():25. PubMed ID: 23394121 [TBL] [Abstract][Full Text] [Related]
24. The Adenosinergic System in Diabetic Retinopathy. Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
26. Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues. Chou CC; Vickroy TW Am J Vet Res; 2003 Feb; 64(2):216-24. PubMed ID: 12602592 [TBL] [Abstract][Full Text] [Related]
27. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Fredholm BB Pharmacol Toxicol; 1995 Feb; 76(2):93-101. PubMed ID: 7746802 [TBL] [Abstract][Full Text] [Related]
28. The perspective of caffeine and caffeine derived compounds in therapy. Pohanka M Bratisl Lek Listy; 2015; 116(9):520-30. PubMed ID: 26435014 [TBL] [Abstract][Full Text] [Related]
30. Effects of caffeine on behavioral and inflammatory changes elicited by copper in zebrafish larvae: Role of adenosine receptors. Cruz FF; Leite CE; Kist LW; de Oliveira GM; Bogo MR; Bonan CD; Campos MM; Morrone FB Comp Biochem Physiol C Toxicol Pharmacol; 2017 Apr; 194():28-36. PubMed ID: 28163255 [TBL] [Abstract][Full Text] [Related]
31. Role of purinergic receptors in the Alzheimer's disease. Cieślak M; Wojtczak A Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042 [TBL] [Abstract][Full Text] [Related]
32. The news advances on Alzheimer's disease's therapeutics. Sun HQ; Zhang X; Huang WJ; Chen WW Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1903-10. PubMed ID: 27212186 [TBL] [Abstract][Full Text] [Related]
33. Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Prasanthi JR; Dasari B; Marwarha G; Larson T; Chen X; Geiger JD; Ghribi O Free Radic Biol Med; 2010 Oct; 49(7):1212-20. PubMed ID: 20638472 [TBL] [Abstract][Full Text] [Related]
34. Upregulated renal adenosine A1 receptors augment PKC and glucose transport but inhibit proliferation. Coulson R; Proch PS; Olsson RA; Chalfant CE; Cooper DR Am J Physiol; 1996 Feb; 270(2 Pt 2):F263-74. PubMed ID: 8779886 [TBL] [Abstract][Full Text] [Related]
35. The role of P2X7R in neuroinflammation and implications in Alzheimer's disease. Chen YH; Lin RR; Tao QQ Life Sci; 2021 Apr; 271():119187. PubMed ID: 33577858 [TBL] [Abstract][Full Text] [Related]
36. Molecular and pharmacodynamic interactions between caffeine and dopaminergic system. Voiculescu M; Ghiță I; Segărceanu A; Fulga I; Coman O J Med Life; 2014; 7 Spec No. 4(Spec Iss 4):30-8. PubMed ID: 27057246 [TBL] [Abstract][Full Text] [Related]
37. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Kumral A; Tuzun F; Yesilirmak DC; Duman N; Ozkan H Acta Paediatr; 2012 Jul; 101(7):e299-303. PubMed ID: 22462821 [TBL] [Abstract][Full Text] [Related]
38. Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer's Disease. Hussain A; Tabrez ES; Mavrych V; Bolgova O; Peela JR Crit Rev Eukaryot Gene Expr; 2018; 28(1):67-72. PubMed ID: 29773015 [TBL] [Abstract][Full Text] [Related]
39. Keep an eye on adenosine: Its role in retinal inflammation. Santiago AR; Madeira MH; Boia R; Aires ID; Rodrigues-Neves AC; Santos PF; Ambrósio AF Pharmacol Ther; 2020 Jun; 210():107513. PubMed ID: 32109489 [TBL] [Abstract][Full Text] [Related]
40. Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model. Mendiola-Precoma J; Padilla K; Rodríguez-Cruz A; Berumen LC; Miledi R; García-Alcocer G J Alzheimers Dis; 2017; 55(3):1273-1283. PubMed ID: 27792010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]